The effect of curcumin supplementation on circulating adiponectin: A systematic review and meta-analysis of randomized controlled trials

Cain Clark, Ehsan Ghaedi, Arman Arab, Makan Pourmasoumi, Amir Hadi

Research output: Contribution to journalReview article

Abstract

Objective: Our objective was to perform a systematic review and meta-analysis on randomized controlled trials (RCTs) assessing the effect of curcumin on serum adiponectin concentration. Methods: We searched PubMed/Medline, Scopus, ISI Web of Science, Cochrane Library, and Google scholar databases up to April 2019. RCTs conducted among human adults studied the effects of curcumin on serum adiponectin concentrations as an outcome variable was included. The weighted mean differences (WMD) and standard deviations (SD) of change in serum adiponectin levels were calculated. The random effects model was used for deriving a summary of mean estimates with their corresponding SDs. Results: Out of 313 records, 6 trials that enrolled 652 subjects were included. The pooled results showed that curcumin supplementation significantly increased adiponectin concentrations in comparison with placebo (WMD: 0.82 Hedges' g; 95% confidence interval (CI): 0.33 to 1.30, P˂0.001). Greater effects on adiponectin were observed in trials lasting ≤10 weeks (WMD: 1.05 Hedges’ g; 95% CI: 0.64 to 1.45, P˂0.001). Conclusion: Curcumin significantly improves adiponectin concentrations. However, due to some limitations in this study, further studies are needed to reach a definitive conclusion about the effect of curcumin on the levels of adiponectin.

Original languageEnglish
Pages (from-to)2819-2825
Number of pages7
JournalDiabetes & Metabolic Syndrome: Clinical Research & Reviews
Volume13
Issue number5
Early online date30 Jul 2019
DOIs
Publication statusPublished - Sep 2019

Fingerprint

Curcumin
Adiponectin
Meta-Analysis
Randomized Controlled Trials
Serum
Library Science
Confidence Intervals
PubMed
Placebos
Databases

Keywords

  • Adiponectin
  • Curcumin
  • Meta-analysis
  • Randomized controlled trials

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

The effect of curcumin supplementation on circulating adiponectin : A systematic review and meta-analysis of randomized controlled trials. / Clark, Cain; Ghaedi, Ehsan; Arab, Arman; Pourmasoumi, Makan; Hadi, Amir.

In: Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Vol. 13, No. 5, 09.2019, p. 2819-2825.

Research output: Contribution to journalReview article

@article{dabdff28dd8f40899fdfe904bb696c31,
title = "The effect of curcumin supplementation on circulating adiponectin: A systematic review and meta-analysis of randomized controlled trials",
abstract = "Objective: Our objective was to perform a systematic review and meta-analysis on randomized controlled trials (RCTs) assessing the effect of curcumin on serum adiponectin concentration. Methods: We searched PubMed/Medline, Scopus, ISI Web of Science, Cochrane Library, and Google scholar databases up to April 2019. RCTs conducted among human adults studied the effects of curcumin on serum adiponectin concentrations as an outcome variable was included. The weighted mean differences (WMD) and standard deviations (SD) of change in serum adiponectin levels were calculated. The random effects model was used for deriving a summary of mean estimates with their corresponding SDs. Results: Out of 313 records, 6 trials that enrolled 652 subjects were included. The pooled results showed that curcumin supplementation significantly increased adiponectin concentrations in comparison with placebo (WMD: 0.82 Hedges' g; 95{\%} confidence interval (CI): 0.33 to 1.30, P˂0.001). Greater effects on adiponectin were observed in trials lasting ≤10 weeks (WMD: 1.05 Hedges’ g; 95{\%} CI: 0.64 to 1.45, P˂0.001). Conclusion: Curcumin significantly improves adiponectin concentrations. However, due to some limitations in this study, further studies are needed to reach a definitive conclusion about the effect of curcumin on the levels of adiponectin.",
keywords = "Adiponectin, Curcumin, Meta-analysis, Randomized controlled trials",
author = "Cain Clark and Ehsan Ghaedi and Arman Arab and Makan Pourmasoumi and Amir Hadi",
year = "2019",
month = "9",
doi = "10.1016/j.dsx.2019.07.045",
language = "English",
volume = "13",
pages = "2819--2825",
journal = "Diabetes and Metabolic Syndrome: Clinical Research and Reviews",
issn = "1871-4021",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - The effect of curcumin supplementation on circulating adiponectin

T2 - A systematic review and meta-analysis of randomized controlled trials

AU - Clark, Cain

AU - Ghaedi, Ehsan

AU - Arab, Arman

AU - Pourmasoumi, Makan

AU - Hadi, Amir

PY - 2019/9

Y1 - 2019/9

N2 - Objective: Our objective was to perform a systematic review and meta-analysis on randomized controlled trials (RCTs) assessing the effect of curcumin on serum adiponectin concentration. Methods: We searched PubMed/Medline, Scopus, ISI Web of Science, Cochrane Library, and Google scholar databases up to April 2019. RCTs conducted among human adults studied the effects of curcumin on serum adiponectin concentrations as an outcome variable was included. The weighted mean differences (WMD) and standard deviations (SD) of change in serum adiponectin levels were calculated. The random effects model was used for deriving a summary of mean estimates with their corresponding SDs. Results: Out of 313 records, 6 trials that enrolled 652 subjects were included. The pooled results showed that curcumin supplementation significantly increased adiponectin concentrations in comparison with placebo (WMD: 0.82 Hedges' g; 95% confidence interval (CI): 0.33 to 1.30, P˂0.001). Greater effects on adiponectin were observed in trials lasting ≤10 weeks (WMD: 1.05 Hedges’ g; 95% CI: 0.64 to 1.45, P˂0.001). Conclusion: Curcumin significantly improves adiponectin concentrations. However, due to some limitations in this study, further studies are needed to reach a definitive conclusion about the effect of curcumin on the levels of adiponectin.

AB - Objective: Our objective was to perform a systematic review and meta-analysis on randomized controlled trials (RCTs) assessing the effect of curcumin on serum adiponectin concentration. Methods: We searched PubMed/Medline, Scopus, ISI Web of Science, Cochrane Library, and Google scholar databases up to April 2019. RCTs conducted among human adults studied the effects of curcumin on serum adiponectin concentrations as an outcome variable was included. The weighted mean differences (WMD) and standard deviations (SD) of change in serum adiponectin levels were calculated. The random effects model was used for deriving a summary of mean estimates with their corresponding SDs. Results: Out of 313 records, 6 trials that enrolled 652 subjects were included. The pooled results showed that curcumin supplementation significantly increased adiponectin concentrations in comparison with placebo (WMD: 0.82 Hedges' g; 95% confidence interval (CI): 0.33 to 1.30, P˂0.001). Greater effects on adiponectin were observed in trials lasting ≤10 weeks (WMD: 1.05 Hedges’ g; 95% CI: 0.64 to 1.45, P˂0.001). Conclusion: Curcumin significantly improves adiponectin concentrations. However, due to some limitations in this study, further studies are needed to reach a definitive conclusion about the effect of curcumin on the levels of adiponectin.

KW - Adiponectin

KW - Curcumin

KW - Meta-analysis

KW - Randomized controlled trials

UR - http://www.scopus.com/inward/record.url?scp=85070065664&partnerID=8YFLogxK

U2 - 10.1016/j.dsx.2019.07.045

DO - 10.1016/j.dsx.2019.07.045

M3 - Review article

VL - 13

SP - 2819

EP - 2825

JO - Diabetes and Metabolic Syndrome: Clinical Research and Reviews

JF - Diabetes and Metabolic Syndrome: Clinical Research and Reviews

SN - 1871-4021

IS - 5

ER -